These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9012480

  • 1. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.
    Pang S, Dannull J, Kaboo R, Xie Y, Tso CL, Michel K, deKernion JB, Belldegrun AS.
    Cancer Res; 1997 Feb 01; 57(3):495-9. PubMed ID: 9012480
    [Abstract] [Full Text] [Related]

  • 2. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 3. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.
    Anticancer Res; 2000 Jan 15; 20(1A):417-22. PubMed ID: 10769689
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S, Tadakuma T, Asano T, Hayakawa M.
    Cancer Res; 2001 Feb 15; 61(4):1276-9. PubMed ID: 11245419
    [Abstract] [Full Text] [Related]

  • 6. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
    Yu DC, Sakamoto GT, Henderson DR.
    Cancer Res; 1999 Apr 01; 59(7):1498-504. PubMed ID: 10197620
    [Abstract] [Full Text] [Related]

  • 7. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.
    Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW.
    J Urol; 1998 Jul 01; 160(1):220-9. PubMed ID: 9628654
    [Abstract] [Full Text] [Related]

  • 8. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J.
    Mol Endocrinol; 1997 Feb 01; 11(2):148-61. PubMed ID: 9013762
    [Abstract] [Full Text] [Related]

  • 9. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
    Chapel-Fernandes S, Jordier F, Lauro F, Maitland N, Chiaroni J, de Micco P, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2006 Oct 01; 13(10):919-29. PubMed ID: 16741521
    [Abstract] [Full Text] [Related]

  • 10. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer.
    Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso CL, Dekernion JB, Belldegrun AS.
    Hum Gene Ther; 1995 Nov 01; 6(11):1417-26. PubMed ID: 8573614
    [Abstract] [Full Text] [Related]

  • 11. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R.
    Cancer Res; 2002 May 01; 62(9):2576-82. PubMed ID: 11980652
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Cancer Res; 1997 Feb 15; 57(4):714-9. PubMed ID: 9044850
    [Abstract] [Full Text] [Related]

  • 13. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
    Wu L, Matherly J, Smallwood A, Adams JY, Billick E, Belldegrun A, Carey M.
    Gene Ther; 2001 Sep 15; 8(18):1416-26. PubMed ID: 11571582
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter.
    Wang J, Zhang H, Liang RX, Pang B, Shi QG, Huang PT, Huang CF, Zhou JG.
    Biochem Biophys Res Commun; 2007 May 25; 357(1):8-13. PubMed ID: 17418805
    [Abstract] [Full Text] [Related]

  • 15. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S, Diamandis EP.
    Br J Cancer; 1999 Mar 25; 79(9-10):1594-602. PubMed ID: 10188912
    [Abstract] [Full Text] [Related]

  • 16. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH, Feng TH, Chung LC, Chao CH, Chang PL, Juang HH.
    Anticancer Res; 2008 Mar 25; 28(4A):1969-76. PubMed ID: 18649734
    [Abstract] [Full Text] [Related]

  • 17. Cloning and characterization of the prostate-specific membrane antigen promoter.
    Good D, Schwarzenberger P, Eastham JA, Rhoads RE, Hunt JD, Collins M, Batzer M, Theodossiou C, Kolls JK, Grimes SR.
    J Cell Biochem; 1999 Sep 01; 74(3):395-405. PubMed ID: 10412041
    [Abstract] [Full Text] [Related]

  • 18. Defining a functional androgen responsive element in the 5' far upstream flanking region of the prostate-specific antigen gene.
    Zhang S, Murtha PE, Young CY.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):784-8. PubMed ID: 9070893
    [Abstract] [Full Text] [Related]

  • 19. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
    Peng W, Chen J, Huang YH, Sawicki JA.
    Gene Ther; 2005 Nov 24; 12(21):1573-80. PubMed ID: 16034457
    [Abstract] [Full Text] [Related]

  • 20. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D.
    Oncogene; 2003 Feb 27; 22(8):1261-72. PubMed ID: 12606954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.